Entod Pharmaceuticals Limited - Company Profile

Q: Who are the current directors of Entod Pharmaceuticals Limited?

The current directors of Entod Pharmaceuticals Limited are Dharmesh Pravin Kharwar, Vivek Manohar Padgaonkar, Kishore Gurudas Masurkar, Vivek Rajendra Shete, Rita Kishore Masurkar, Vinay Gurudas Masurkar, Nikhil Kishore Masurkar.

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1981.

1981 Mumbai, Maharashtra, India Active

Last Updated: January 06, 2026

Access Report

About Entod Pharmaceuticals Limited

Entod Pharmaceuticals Limited, a active public limited company, was established on 31 October 1981 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230MH1981PLC025529. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹1.06 Cr.

It upholds a compliant status. Employing 1,092 professional, Its leadership includes Dharmesh Pravin Kharwar (Director), Vivek Manohar Padgaonkar (Director), Kishore Gurudas Masurkar (Whole-Time Director). Past directors included Sanjay Shrikisan Navandar, Dharmesh Pravin Kharwar, Vivek Manohar Padgaonkar. It holds ₹25.55 Cr open charges and ₹22.88 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Ashirwad Bldg Oppbaoi Masjid S V Rd Bandra (W), Mumbai, Maharashtra, 400050.

Company Details

CIN/LLPIN
U24230MH1981PLC025529
Registration Number
025529
Incorporation Date
31 October 1981
Authorized Capital
₹3.00 Cr
Paid-Up Capital
₹1.06 Cr
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 3.00 Cr as on 06-01-2026
Paid Up Capital ₹ 1.06 Cr as on 06-01-2026
Company Age 44 Year, 4 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 25.55 Cr as on 06-01-2026
Satisfied Charges ₹ 22.88 Cr as on 06-01-2026

Comprehensive Company Insights

Explore comprehensive insights into Entod Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Entod Pharmaceuticals Limited?

Current Directors

Name	Designation	Appointment Date	Status
Dharmesh Pravin Kharwar	Director	20 Aug 2024	Current
Vivek Manohar Padgaonkar	Director	29 Jul 2024	Current
Kishore Gurudas Masurkar	Whole-Time Director	31 Oct 1981	Current
Vivek Rajendra Shete	Director	15 Jan 2022	Current
Rita Kishore Masurkar	Director	01 Oct 2011	Current
Vinay Gurudas Masurkar	Director	25 Sep 2009	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	04 Sep 2009	Past
Pramod Abcsdd	Additional Director	29 Sep 2024	Past
Pramod Abcsdd	Additional Director	29 Sep 2024	Past
Pramod Abcsdd	Additional Director	30 Aug 2008	Past
Pramod Abcsdd	Additional Director	28 Oct 2011	Past
Pramod Abcsdd	Additional Director	04 Sep 2009	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Entod Pharmaceuticals.

Entod Pharmaceuticals Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Entod Pharmaceuticals?

In 2023, Entod Pharmaceuticals had a promoter holding of 99.45% and a public holding of 0.55%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹255,482,000.00

Satisfied Charges

₹228,811,000.00

Charges Breakdown by Lending Institutions

Others : 25.55 Cr

Latest Charge Details

Date	Lender	Amount	Status
23 Sep 2025	Others	₹5.48 M	Open
04 Aug 2025	Others	₹25.00 Cr	Open
24 Jun 2021	Hdfc Bank Limited	₹6.00 M	Satisfied
09 Mar 2021	Others	₹1.10 M	Satisfied
15 Nov 2017	Others	₹3.00 M	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Entod Pharmaceuticals?

Entod Pharmaceuticals has a workforce of 1092 employees as of Apr 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Entod Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Entod Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Entod Pharmaceuticals

Recent Activity within the Organization

Charges

The activity A charge registered on 13 Oct 2016 via Charge ID 100057531 with Hdfc Bank Limited was fully satisfied on 25 Nov 2025. was completed.
25 Nov 2025
Annual General Meeting

The activity Entod Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was completed.
29 Sep 2025
Charges

Progress on A charge with Others amounted to Rs. 0.55 Cr with Charge ID 101163526 was registered on 23 Sep 2025. was documented.
23 Sep 2025
Charges

The activity A charge registered on 09 Mar 2021 via Charge ID 100431985 with Others was fully satisfied on 07 Aug 2025. was completed.
07 Aug 2025
Charges

Progress on A charge with Others amounted to Rs. 25.00 Cr with Charge ID 101133834 was registered on 04 Aug 2025. was documented.
04 Aug 2025
Balance Sheet

Entod Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
31 Mar 2025

Explore recent activity and updates - View Recent Activity